Literature DB >> 25088011

Abatacept induces clinical improvement in patients with severe systemic sclerosis.

F V de Paoli1, B D Nielsen, F Rasmussen, B Deleuran, K Søndergaard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25088011     DOI： 10.3109/03009742.2013.812238

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN： 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  12 in total

Review 1.  [Pemphigus. Model disease for targeted therapy].

Authors:  R Eming
Journal:  Hautarzt       Date:  2015-08       Impact factor: 0.751

Review 2.  Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches.

Authors:  Robert Pollmann; Thomas Schmidt; Rüdiger Eming; Michael Hertl
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  Genetic architectures of seropositive and seronegative rheumatic diseases.

Authors:  Yohei Kirino; Elaine F Remmers
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

4.  The role of B7 family costimulatory molecules and indoleamine 2,3-dioxygenase in primary Sjögren's syndrome and systemic sclerosis.

Authors:  Nóra Legány; László Berta; László Kovács; Attila Balog; Gergely Toldi
Journal:  Immunol Res       Date:  2017-06       Impact factor: 2.829

5.  Immunotherapy of systemic sclerosis.

Authors:  Christina G Katsiari; Theodora Simopoulou; Ioannis Alexiou; Lazaros I Sakkas
Journal:  Hum Vaccin Immunother       Date:  2018-07-16       Impact factor: 3.452

Review 6.  Inflammatory arthritis in systemic sclerosis: What to do?

Authors:  Rebecca B Blank; Ogonna Kenechi Nwawka; Anna A Yusov; Jessica K Gordon
Journal:  J Scleroderma Relat Disord       Date:  2018-06-19

Review 7.  Is biological therapy in systemic sclerosis the answer?

Authors:  Durga Prasanna Misra; Sakir Ahmed; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2020-01-20       Impact factor: 2.631

8.  CD4+ Group 1 Innate Lymphoid Cells (ILC) Form a Functionally Distinct ILC Subset That Is Increased in Systemic Sclerosis.

Authors:  Florence Roan; Thomas A Stoklasek; Elizabeth Whalen; Jerry A Molitor; Jeffrey A Bluestone; Jane H Buckner; Steven F Ziegler
Journal:  J Immunol       Date:  2016-01-29       Impact factor: 5.422

Review 9.  Targeting Costimulatory Pathways in Systemic Sclerosis.

Authors:  Gonçalo Boleto; Yannick Allanore; Jérôme Avouac
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

10.  B7-H3 participates in human salivary gland epithelial cells apoptosis through NF-κB pathway in primary Sjögren's syndrome.

Authors:  Ping Li; Ying Yang; Yi Jin; Rui Zhao; Chen Dong; Wenjie Zheng; Tianyi Zhang; Jing Li; Zhifeng Gu
Journal:  J Transl Med       Date:  2019-08-14       Impact factor: 5.531
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.